| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0003 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |